Regeneron Lifts Stake In Biotech Partner ISA Pharma

Equity Injection Part Of €26m Funding To Advance ISA’s Pipeline

ISA to advance lead asset ISA101b, widen pipeline of immunotherapies • Source: Alamy

More from Clinical Trials

More from R&D